CDKN2B and coronary artery disorder: As shown in Table 2 and Figs 4, 7 and 8 CpG sites within the 2nd CpG island located upstream of CDKN2B-AS1 were hyper-methylated in CAD subjects compared to the matched controls (p = 0.034).